Regeneron to Report Second Quarter 2013 Financial and Operating Results and Host Conference Call and Webcast on August 6, 2013

 Regeneron to Report Second Quarter 2013 Financial and Operating Results and
              Host Conference Call and Webcast on August 6, 2013

PR Newswire

TARRYTOWN, N.Y., July 2, 2013

TARRYTOWN, N.Y., July 2, 2013 /PRNewswire/ -- Regeneron Pharmaceuticals, Inc.
(NASDAQ: REGN)  today announced that it will report its second quarter 2013
financial and operating results on Tuesday, August 6, 2013, before the U.S.
financial markets open. The Company will host a conference call and
simultaneous webcast at 8:30 AM Eastern Time that day.

Conference Call Information
To access this call, dial (888) 660-6127 (U.S.) or (973) 890-8355
(International). A link to the webcast may be accessed from the 'Events and
Presentations' page of Regeneron's website at www.regeneron.com.A replay of
the conference call and webcast will be archived on the Company's website and
will be available for 30 days.

About Regeneron Pharmaceuticals
Regeneron is a leading science-based biopharmaceutical company based in
Tarrytown, New York that discovers, invents, develops, manufactures, and
commercializes medicines for the treatment of serious medical
conditions.Regeneron markets medicines for eye diseases, colorectal cancer,
and a rare inflammatory condition and has product candidates in development in
other areas of high unmet medical need, including hypercholesterolemia,
oncology, rheumatoid arthritis, allergic asthma, and atopic dermatitis. For
additional information about the company, please visit www.regeneron.com.

Contact Information:
Manisha Narasimhan, Ph.D.       Peter Dworkin
Investor Relations          Corporate
                                                         Communications
914-847-5126 914-847-7640 
manisha.narasimhan@regeneron.com        peter.dworkin@regeneron.com

SOURCE Regeneron Pharmaceuticals, Inc.

Website: http://www.regeneron.com